AssetMark Inc’s Apellis Pharmaceuticals APLS Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $190 | Sell |
11
-1,241
| -99% | -$21.4K | ﹤0.01% | 2886 |
|
|
2025
Q1 | $27.4K | Buy |
1,252
+1,221
| +3,939% | +$26.7K | ﹤0.01% | 1619 |
|
|
2024
Q4 | $989 | Sell |
31
-46,034
| -100% | -$1.47M | ﹤0.01% | 2247 |
|
|
2024
Q3 | $1.33M | Buy |
46,065
+2,852
| +7% | +$82.3K | ﹤0.01% | 736 |
|
|
2024
Q2 | $1.66M | Buy |
43,213
+21,466
| +99% | +$823K | 0.01% | 657 |
|
|
2024
Q1 | $1.28M | Buy |
21,747
+4,403
| +25% | +$259K | ﹤0.01% | 677 |
|
|
2023
Q4 | $1.04M | Buy |
17,344
+5,975
| +53% | +$358K | ﹤0.01% | 667 |
|
|
2023
Q3 | $432K | Buy |
11,369
+5,339
| +89% | +$203K | ﹤0.01% | 783 |
|
|
2023
Q2 | $549K | Buy |
6,030
+1,220
| +25% | +$111K | ﹤0.01% | 713 |
|
|
2023
Q1 | $317K | Buy |
+4,810
| New | +$317K | ﹤0.01% | 771 |
|